3rd International Consultation on Sexual Medicine (2009)
Message of the chairman
The Third International Consultation on Sexual Medicine (ICSM), which took place on July 10 to July 13, 2009 at the Palais de Congres in Paris, France was organized under the auspices of the International Consultation on Urological Diseases and the International Society for Sexual Medicine (ISSM). This year’s ICSM was a truly memorable scientific event full of impressive discoveries, never before seen studies backed by robust data and an overwhelming interest from the audience. After having watched and listened to each and every one of the presentations given during the four
day meeting, we are pleased to affirm that the field of Sexual Medicine for both Men and Women is making enormous progress. This well deserved success is due to the dedication, perseverance and hard work done by the renowned experts in the field who selflessly devote their time, intellect and energy to promoting the results and findings obtained by their studies.
To successfully carry out a meeting and publication as important as this, careful preparation was necessary. In early 2008, Chairman Francesco Montorsi, Secretary Saad Khoury, Honorary President Tom Lue and Vice Chairs; Ganesan Adaikan, Rosemary Basson, Edgardo Becher, Anita Clayton, Francois Giuliano, Ira Sharlip all met together in person or by phone conference in Paris with the ISSM office representatives to brainstorm on how a reference such as the Recommendations for Sexual Medicine should be developed. Much thought and consideration went into deciding what topics should be considered as chapters and how the meeting and eventual publication would be organized.
Choosing the Chairpersons, Members and Consultants was not an easy task as the experts in these fields are many and each very distinguished. The identification of the members of all the committees started from a very rigorous assessment of the chairpersons and members of the 2003 Consultation as we clearly wanted to have on board again all those who had given a substantial contribution to that meeting and were still available to actively participate this further endeavour.
In addition, a very extensive PubMed search and a thorough evaluation of the scientific programmes of the most important international scientific meetings devoted to sexual medicine served to identify the names of the top experts from the five continents.
The topics that were discussed in the 2003 Consultation served as the basis to build the programme of the 2009 meeting. We considered the advances done in the field during the last six years and we identified all the areas which deserved to be specifically investigated by the experts of the new Consultation. In the end, we were able to produce a table of contents composed of 25 Chapters covering a vast spectrum of the critical topics concerning aspects of sexual medicine for both men and women.
The lists of topics and experts were then matched and the committees were formed. Although a few of those on each of our“wish lists”could not be included due to economic restraints, we were able to guarantee the participation of 186 experts to the final program.
The preparatory meetings held at the various major national meetings, the ISSM in Brussels and the American Urological Association 2009 annual meeting in Chicago, were essential to understand how each chapter was progressing and what the next steps should be. These meetings allowed everyone to finally meet face-to-face under the same roof to streamline ideas and final recommendations of their respective chapters. We were impressed to see the close collaboration the committees had with one another to make sure that ideas were shared without overlap.
The work of the various committees was indeed very hard and was witnessed by the exchange of a huge number of emails aimed at discussing the contents of the various chapters. We are very pleased to inform you that we were always able to touch with our hands the enthusiasm and passion for science shown by the chairs and members of the committees. Sometimes there were strong views which would be contrasting but at the end it was always possible to find a general consensus and the final editing of the chapters text was overall very smooth.
In Paris, the presentations of the committees were really top quality and it was clear to the audience that a huge amount of work was behind the slides that were shown. The discussion sessions were always very lively and many ideas that came out of these were used to improve the final text of the chapters.
In the end, we believe that our objective to create and update a set of standards from evidence based studies and years of research has been reached. This gratifying accomplishment could not have been made without the support from the previously mentioned organizations, the various sponsors and the ambitious staff of the Consultation.
We are grateful to everyone involved and especially to Ira Sharlip who was instrumental in maintaining the necessary geographical balance when identifying the top experts and also in obtaining funding for the meeting; to Tom Lue and all the Vice Chairs who were extremely active during all the preparatory phases and to David Casalod and his team who were the responsible persons for the very efficient logistics.
We are convinced that these contributions will be key in advancing our knowledge in the field of sexual medicine and ultimately in improving the care of our patients.
- FRANCESCO MONTORSI
- CATHERINE J. PIERCE
Assistant to the Chairman, ICSM
- SAAD KHOURY
- F. Montorsi,
- R. Basson,
- G. Adaikan
- E. Becher,
- A. Clayton,
- F. Giuliano,
- S. Khoury,
- I. Sharlip
Committee 1: Historical highlights of sexual dysfunctions in men and women
Sidney Glina, Brazil, Dirk Schultheiss, Germany, Gorm Wagner, Denmark
Committee 2: Definitions, classification and epidemiology of sexual dysfunction
Kerstin Fugl Meyer, Sweden, Ron Lewis, USA, Giovanni Corona, Italy,
William Fisher, Canada, Edward Laumann, USA, Edson Moreira, Brazil,
Alessandra Rellini, Italy, Taylor Segraves, USA, Consultant Dale Glasser, USA
Committee 3: Psychological and interpersonal dimensions of sexual function and dysfunction
Stanley Althof, USA, Marita McCabe, Australia, Pierre Assalian, Canada, Marie Chevret-Measson, France, Sandra Leiblum, USA, Chiara Simonelli, Italy, Kevan Wylie, UK
Committee 4: Ethical, socio-cultural and educational aspects of sexual medicine
John Dean, UK, Khaled Dabees, Egypt, Sharon Parish, USA, Eusebio Rubio-Aurioles, Mexico, Leonore Tiefer, USA, Consultant Fernando Ugarte y Romano, Mexico
Committee 5: Economic aspects of sexual dysfunction
Geoff Hackett, UK, Ridwan Shabsigh, USA, Nicolae Calomfirescu, Romania, Yasusuke Kimoto, Japan, Siegfried Meryn, Austria, Luis Otavio Torres, Brazil,
Consultants Carolyn Earle, Australia, Prithy, Ramlachan, South Africa
Committee 6: Clinical evaluation and symptom scales: sexual dysfunction assessment
Dimitris Hatzichristou, Greece, Raymond Rosen, USA, Leonard Derogatis, USA, Eric Meuleman, Netherlands, Michael O’Leary, USA, Yoram Vardi, Israel, Wah Yun Low, Malaysia, Consultants Mariano Sotomayor De Zava, Mexico, Tara Symonds, UK
Committee 7: Experimental models for the study of female and male sexual function
Francois Giuliano, France, Kim Wallen, USA, Petter Hedlund, Sweden, Leslie Marson, USA, Jim Pfaus, Canada, Balasubramanian Srilatha,Singapore, Consultant Shin-ichi Hisaue, Japan
Committee 8: Cardiovascular aspects of sexual medicine
Graham Jackson, UK, Piero Montorsi, Italy, Michael Adams, Canada, Tarek Anis, Egypt, Ahmed El Sakka, Saudi Arabia, Charalambos Vlachopoulos, Greece, Consultant Edward Kim, USA
Committee 9: Sexual function in chronic illness and cancer
Rosemary Basson, Canada, Luca Incrocci, Netherlands, Michael Krychman, USA, Angel Luis Montejo, Spain, Antonio Martin Morales, Spain, Peter Rees, Canada, Leslie Schover, USA, Run Wang, USA
Committee 10: Sexually transmitted diseases and sexual function
Hossein Sadeghi Nejad, USA, Marlene Wasserman, South Africa, David Goldmeier, UK, Lucia O’Sullivan, Canada, Wolfgang Weidner, Germany
Committee 11: Future treatment targets for sexual dysfunctions
Arthur Burnett, USA, Irwin Goldstein, USA, Karl-Eric Andersson, Sweden, Antonio Argiolas, Italy, George Christ, USA, ZhongCheng Xin, China
Committee 12: Standards for clinical trials in male sexual dysfunctions
Hartmut Porst, Germany, Yoram Vardi, Israel, Emre Akkus, Turkey, Jamie Barada, USA, Serge Carrier, Canada, Arnold Melman, USA, Nam Cheol Park, South Korea, Allen Seftel, USA, Claudio Teloken, Brazil, Mike Wyllie, UK
Committee 13: Physiology and pathophysiology of Men’s Sexual Arousal and Penile Erection
Tom Lue, USA, Christian Stief, Germany, Javier Angulo, Spain, Yutain Dai, China, Noel Kim, USA, Stephan Uckert, Germany, Eric Wespes, Belgium, Consultants Kanchan Chitaley, USA, Jae-Seung Paick, South Korea, Ulf Simonsen, Denmark
Committee 14: Endocrine aspects of male sexual dysfunction
Jacques Buvat, France, Mario Maggi, Italy, Abraham Morgentaler, USA, Claude Schulman, Belgium, Michael Zitzman, Germany, Consultants Andre Guay, USA, Joel M. Kaufman, USA, Hui Meng Tan, Malaysia, Luiz Otavio Torres, Brazil
Committee 15: Priapism
Gregory Broderick, USA, Ates Kadioglu, Turkey, Trinity Bivalacqua, USA, Hussein Ghanem, Egypt, Ajay Nehra, USA, Rany Shamloul, Canada
Committee 16: La Peyronie’s Disease, penile trauma and gender reassignment surgery
Lawrence Levine, USA, David Ralph, UK, Thierry Lebret, France, Vincenzo Mirone, Italy, Michael Sohn, Germany, Consultants Nestor Gonzalez Cadavid, USA, Sava Perovic, Serbia, Mustafa Usta, Turkey
Committee 17: Disorders of orgasm and ejaculation in men
Chris McMahon, Australia, David L. Rowland, USA, Carmita Abdo, Brazil, Juza Chen, Israel, Emmanuele Jannini, Italy, Marcel Waldinger, Netherlands, Consultant Tai Young Ahn, South Korea
Committee 18: Implants, mechanical devices and vascular surgery for erectile dysfunction
Wayne Hellstrom, USA, Karl Montague, USA, Culley Carson, USA, Sudhakar Krishnamurti, India, Suks Minhas, UK, Ignacio Moncada, Spain, Consultant Geraldo Faria, Brazil
Committee 19: Pharmacotherapy for erectile dysfunction
Craig Donatucci, USA, Ian Eardley, UK, Jackie Corbin, USA, Kostas Hatzimouratidis, Greece, Kevin McVary, USA, Consultants Ricardo Munarriz, USA, Sun Won Lee, South Korea
Committee 20: Sexual rehabilitation after treatment for prostate cancer
Gerald Brock, Canada, John Mullhall, USA, Alberto Briganti, Italy, Klaus Peter Juenemann, Germany, Andrew McCullough, USA, Consultants Anthony Bella, Canada, Ray Costabile, USA
Committee 21: Standards for clinical trials in sexual dysfunctions of women: research designs and outcomes assessment
Anita Clayton, USA, Lorraine Dennerstein, Australia, Andre Guay, USA, Sheryl Kingsberg, USA, Michael Perelman, USA
Committee 22: Physiology of women’s sexual function and pathophysiology of women’s sexual dysfunction
Annamaria Giraldi, Denmark, Andrea Salonia, Italy, Meredith Chivers, Canada, Janniko Georgiadis, Netherlands, Ken Maravilla, USA, Margaret McCarthy, USA, Helen O’Connell, Australia, Consultant Roy Levine, USA
Committee 23: Endocrine aspects of women’s sexual dysfunction
Rossella Nappi, Italy, Margaret Wierman, USA, Wiebke Arlt, UK, Nancy Avis, USA, Susan Davis, Australia, Fernand Labrie, Canada, William Rosner, USA, Jan Shifren, USA
Committee 24: Women’s sexual desire and arousal disorders
Lori Brotto, Canada, Johanes Bitzer, Switzerland, Ellen Laan, Netherlands, Sandra Leiblum, USA, Mijal Luria, Israel
Committee 25: Women’s sexual pain disorders
Jacques van Lankveld, Netherlands, Irv M. Binik, Canada, Michal Granot, Israel, Alessandra Graziottin, Italy, Willibrord Weijmar Schultz, Netherlands, Consultants Nina Bohm-Starke, Sweden, Caroline Pukall, Canada, Ursula Wesselmann, USA